PHR
Undervalued by 33.6% based on the discounted cash flow analysis.
Market cap | $1.26 Billion |
---|---|
Enterprise Value | $1.18 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-2.51 |
Beta | 2.24 |
Outstanding Shares | 56,387,472 |
Avg 30 Day Volume | 462,409 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -9.17 |
---|---|
PEG | 47.27 |
Price to Sales | 3.71 |
Price to Book Ratio | 5.57 |
Enterprise Value to Revenue | 3.31 |
Enterprise Value to EBIT | -8.64 |
Enterprise Value to Net Income | -9 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.05 |
No data
No data
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...